Clinical Treatment Protocol References:

1.    Delbridge, E. and J. Proietto, State of the science: VLED (very Low Energy Diet) for obesity. Asia Pacific Journal Clinical Nutrition, 2006. 15 (Suppl): p. 49-54.
2.    Mustajoki, P. and T. Pekkarinen, Very low energy diets in the treatment of obesity. Obesity Reviews, 2001. 2: p. 61-72.
3.    National Health and Medical Research Council., Clinical Practice Guidelines for the Management of Overweight and Obesity in Adults, Adolescents and Children in Australia. National Health ad Medical Research Council, 2013.
4.    Obesity, T.N.T.o.t.P.a.T.o., Very Low-Calorie Diets. J Am Medical Assoc, 1993. 270(8): p. 967-974.
5.    Purcell, K., et al., The effect of rate of weight loss on long-term weight management: a randomised controlled trial. The Lancet Diabetes & Endocrinology, 2014. 2(12): p. 954-962.
6.    Gibson, A.A., et al., Do ketogenic diets really suppress appetite? A systematic review and meta-analysis. Obes Rev, 2015. 16(1): p. 64-76.
7.    Friis, R., et al., Effect of rapid weight loss with supplemented fasting on liver tests. J Clin Gastroenterol, 1987. 9(2): p. 204-7.
8.    Gibson, A.A., et al., Comparison of Very Low Energy Diet Products Available in Australia and How to Tailor Them to Optimise Protein Content for Younger and Older Adult Men and Women. Healthcare (Basel), 2016. 4(3).
9.    Haywood, C.J., et al., Very Low-Calorie Diets for Weight Loss in Obese Older Adults-A Randomized Trial. J Gerontol A Biol Sci Med Sci, 2017.
10.    Dutheil, F., et al., Treatment of metabolic syndrome by combination of physical activity and diet needs an optimal protein intake: a randomised controlled trial. Nutr J, 2012. 11: p. 72.
11.    Volek, J.S. and S. Phinney, The Art & Science of Low Carbohydrate Living. 2011.
12.    Tsagareli, V., M. Noakes, and R.J. Norman, Effect of a very-low-calorie diet on in vitro fertilisation outcomes. Fertil Steril, 2006. 86(1): p. 227-9.
13.    Sim, K.A., S.R. Partridge, and A. Sainsbury, Does weight loss in overweight or obese women improve fertility treatment outcomes? A systematic review. Obes Rev, 2014. 15(10): p. 839-50.
14.    Stewart, R., Handbook of Clinical Nutrition and Dietetics 3rd Edition. Campbell House.
15.    Breen, H.B. and C.S. Ireton-Jones, Predicting energy needs in obese patients. Nutr Clin Pract, 2004. 19(3): p. 284-9.
16.    NHMRC. Nutrient Reference Values for Australia and New Zealand. 2005; Available from: https://www.nrv.gov.au/.
17.    Foundation, N.H., Fish, Fish Oils, n-3 polyunsaturated fatty acids and cardiovascular health. 2008.
18.    Kraemer, W.J., et al., Influence of exercise training on physiological and performance changes with weight loss in men. Med Sci Sports Exerc, 1999. 31(9): p. 1320-9.
19.    Donnelly, J.E., et al., Effects of a very-low-calorie diet and physical-training regimens on body composition and resting metabolic rate in obese females. Am J Clin Nutr, 1991. 54(1): p. 56-61.
20.    Geliebter, A., et al., Effects of strength or aerobic training on body composition, resting metabolic rate, and peak oxygen consumption in obese dieting subjects. Am J Clin Nutr, 1997. 66(3): p. 557-63.
21.    Jakicic, J., The Role of Physical Activity in Prevention and Treatment of Body Weight Gain in Adults. American Society for Nutritional Sciences, 2002. 132: p. 3826S-3829S.
22.    Haskell, W.L., et al., Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation, 2007. 116(9): p. 1081-93.
23.    Klem, M.L., et al., A descriptive study of individuals successful at long-term maintenance of substantial weight loss. Am J Clin Nutr, 1997. 66(2): p. 239-46.
24.    Andersen, R.E., et al., Effects of lifestyle activity vs structured aerobic exercise in obese women: a randomised trial. Jama, 1999. 281(4): p. 335-40.
25.    Jakicic, J.M., et al., Effects of intermittent exercise and use of home exercise equipment on adherence, weight loss, and fitness in overweight women: a randomised trial. Jama, 1999. 282(16): p. 1554-60.
26.    Jakicic, J.M., et al., Prescribing exercise in multiple short bouts versus one continuous bout: effects on adherence, cardiorespiratory fitness, and weight loss in overweight women. Int J Obes Relat Metab Disord, 1995. 19(12): p. 893-901.
27.     Department of Health and Aging., Physical Activity Gruidelines for Adults. 18-64. 2014.
28.    Lantz, H., et al., Intermittent versus on-demand use of a very low-calorie diet: a randomised 2-year clinical trial. Journal of Internal Medicine, 2003. 253: p. 463-471.
29.    Ryttig, K.R. and S. Rossner, Weight maintenance after a very low-calorie diet (VLCD) weight reduction period and the effects of VLCD supplementation. A prospective, randomised, comparative, controlled long-term trial. Journal of Internal Medicine, 1995. 238: p. 299-306.
30.    Pekkarinen, T. and P. Mustajoki, Use of Very Low-Calorie Diet in Preoperative Weight Loss: Efficacy and Safety. Obesity Research, 1997. 5(6): p. 595-602.
31.    Alami, R.S., et al., Is there a benefit to preoperative weight loss in gastric bypass patients? A prospective randomised trial. Surg Obes Relat Dis, 2007. 3(2): p. 141-5; discussion 145-6.
32.    Tarnoff, M., L.M. Kaplan, and S. Shikora, An evidenced-based assessment of preoperative weight loss in bariatric surgery. Obes Surg, 2008. 18(9): p. 1059-61.
33.    Colles, S., et al., Preoperative weight loss with a very low energy diet: quantitation of changes in liver and abdominal fat by serial imaging. Am J Clin Nutr, 2006. 84: p. 304-311.
34.    Snyder-Marlow, G., D. Taylor, and M.J. Lenhard, Nutrition care for patients undergoing laparoscopic sleeve gastrectomy for weight loss. J Am Diet Assoc, 2010. 110(4): p. 600-7.
35.    Martin, L.F., et al., Can Morbidly Obese Patients Safely Lose Weight Preoperatively? The American Journal of Surgery, 1995. 169: p. 245-253.
 

  • Overview of Very Low Energy Diets

    Very Low Energy Diets (VLED), also known as Very Low Calorie Diets (VLCD) have been shown to be very effective in the management of obesity, with weekly weight losses averaging approximately 1.0 -2.5kg per week, providing greater initial weight loss than other forms of calorie restriction.

  • Expected rate of weight loss on Intensive Level

    During the Intensive Level of the OPTIFAST Program, weight loss averages 1.0 to 2.5kg/week with an average total loss of 20kg after 12 to 16 weeks.

  • Long term weight loss goals

    It is often mentioned in the lay press and amongst healthcare professionals that "the faster you lose weight, the quicker you regain it", yet there is little evidence to support this assumption and in fact the opposite may be true.

  • Mechanics of a VLED

    A VLED works by restricting total energy intake to approximately 800 calories (3300kJ) or less per day. Weight loss with a VLED is achieved by restriction of both carbohydrate and total energy intake. This enables the body to use its body fat stores for energy via a metabolic process called ketosis.

  • Patient suitability

    For a patient to succeed with the OPTIFAST VLCD Program, it is important to assess their readiness to undertake the necessary behaviour changes required for effective weight management.

  • Calculating ideal body weight

    Ideal body weight is calculated to help determine an appropriate weight for height or to determine a long term weight loss goal. We recommend that you use the ‘Adjusted Ideal Body Weight’ calculation.

  • Calculating protein requirements

    OPTIFAST VLCD is formulated to contain adequate high quality protein in sufficient quantities for nitrogen sparing and to preserve lean body mass.

  • Medical monitoring

    As a healthcare professional, you can tailor the program to suit your patient's specific needs.

  • Long-term weight management with the OPTIFAST VLCD Program

    Research has shown that having the support and guidance of a healthcare professional will make the program more successful for your patients.

  • Bariatric surgery and the OPTIFAST VLCD Program

    Surgical intervention by way of bariatric surgery can result in substantial weight loss that is sustained over the long term when combined with education, ongoing monitoring and patient support.

  • Diabetes and the OPTIFAST VLCD Program

    Most overweight and obese patients with Type 1 or Type 2 diabetes are eligible to use OPTIFAST VLCD as part of an overall management program that emphasises the importance of ongoing weight maintenance.

  • References